European Companies Search Engine
Managing Director (2) · No longer Managing Director (1) · Change of headquarters: VITAFLO Pharma GmbH · Capital: €150,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb11 Jan 2008 German Trade Register Announcements, Germany (10/01/2008)
Overview
Text
VITAFLO Pharma GmbH, Bad Homburg v. d. Höhe (
Unnamed street ??, 61352 Bad Homburg v. d. Höhe, Germany
). GmbH. Partnership agreement of April 26, 2004 with amendment of June 1, 2005. The shareholders' meeting of November 5, 2007 decided to amend the partnership agreement in Section 1 (2) (seat) and with it the transfer of its registered office from Bad Vilbel (previously Amtsgericht Frankfurt am Main HRB 74927) to Bad Homburg v. d. Höhe. Like-for-like increases in the share capital by EUR 125,000.00 to EUR 150,000.00, the partnership agreement was amended accordingly in Section 3. The ado is the authorisation and distribution of medicinal products, chemicals, medical devices, food and food supplements, as well as all related and related transactions and all related activities. Share capital: EUR 150,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Directors: ??????, ??????? ?????? ???, Glasgow, United Kingdom, *??.??.????; ??????????, ?????? ???????, Liverpool, United Kingdom, *??.??.????, each with individual representatives; with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party. No longer Managing Director: Dr. ???????, ?????, Karben, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vitaflo Deutschland GmbH, Steinbach (Taunus), Germany.
